We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The tuberculous infection control strategy, FAST (Find cases Actively, Separate safely and Treat effectively)
Guidance for commissioners on how to estimate the cost-effectiveness of local spending on treatment for alcohol and drug misuse.
Article in the Archives of Internal Medicine journal
How to use a cost effectiveness analysis to evaluate your digital health product.
Information for patients, healthcare professionals and developers of new medicines
How to use a before-and-after study to evaluate your digital health product.
Outcome monitoring forms and guidance on how alcohol and drug treatment outcomes information is collected and how it can be used to improve local services.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice for drug treatment and recovery workers to help them to deliver safe and effective OST to service users.
The objective of this study is to assess the incremental cost-effectiveness of 2 projects
New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.